Multifunctional tacrine derivatives in Alzheimer's disease

A Minarini, A Milelli, E Simoni, M Rosini… - Current topics in …, 2013 - ingentaconnect.com
Tacrine (1) was the first acetylcholinesterase inhibitor (AChEI) introduced in therapy for the
treatment of Alzheimer's disease (AD), but similarly to the most recent approved AChEIs and …

Role of chaperone-mediated autophagy dysfunctions in the pathogenesis of Parkinson's disease

G Sala, D Marinig, A Arosio… - Frontiers in molecular …, 2016 - frontiersin.org
Chaperone-mediated autophagy (CMA) represents a selective form of autophagy involved
in the degradation of specific soluble proteins containing a pentapeptide motif that is …

MiR‐29c protects against inflammation and apoptosis in Parkinson's disease model in vivo and in vitro by targeting SP1

R Wang, Y Yang, H Wang, Y He… - Clinical and Experimental …, 2020 - Wiley Online Library
MicroRNAs (miRNAs) have been shown to have complicated implications in the
pathogenesis of Parkinson's disease (PD). However, the role of miR‐29c and the underlying …

Epigenetic modulation in Parkinson's disease and potential treatment therapies

AS Rathore, H Birla, SS Singh, W Zahra… - Neurochemical …, 2021 - Springer
In the recent past, huge emphasis has been given to the epigenetic alterations of the genes
responsible for the cause of neurological disorders. Earlier, the scientists believed somatic …

Overexpression of the Transcription Factor MEF2D in Hepatocellular Carcinoma Sustains Malignant Character by Suppressing G2–M Transition Genes

L Ma, J Liu, L Liu, G Duan, Q Wang, Y Xu, F Xia, J Shan… - Cancer research, 2014 - AACR
The underlying molecular pathogenesis in hepatocellular carcinoma remains poorly
understood. The transcription factor MEF2D promotes survival in various cell types and it …

Mitochondrial dysfunction and apoptosis are attenuated through activation of AMPK/GSK-3β/PP2A pathway in Parkinson's disease

J Su, J Zhang, R Bao, C Xia, Y Zhang, Z Zhu… - European Journal of …, 2021 - Elsevier
Parkinson's disease (PD) is a common neurological disorder worldwide, characterized by
loss of dopaminergic neurons and decrease of dopamine content. Mitochondria plays an …

The MEF2 family and the brain: from molecules to memory

JB Dietrich - Cell and tissue research, 2013 - Springer
The MEF2 (myocyte enhancer factor 2) family of transcription factors is composed of four
distinct vertebrate genes. These factors were first identified in muscle but are also present in …

[HTML][HTML] Minocycline, levodopa and MnTMPyP induced changes in the mitochondrial proteome profile of MPTP and maneb and paraquat mice models of Parkinson's …

A Dixit, G Srivastava, D Verma, M Mishra… - … et Biophysica Acta (BBA …, 2013 - Elsevier
Mitochondrial dysfunction is the foremost perpetrator of the nigrostriatal dopaminergic
neurodegeneration leading to Parkinson's disease (PD). However, the roles played by …

Neuroprotective Effects of Salidroside in the MPTP Mouse Model of Parkinson's Disease: Involvement of the PI3K/Akt/GSK3β Pathway

W Zhang, H He, H Song, J Zhao, T Li, L Wu… - Parkinson's …, 2016 - Wiley Online Library
The degenerative loss through apoptosis of dopaminergic neurons in the substantia nigra
pars compacta plays a primary role in the progression of Parkinson's disease (PD). Our in …

Multifunction of chrysin in Parkinson's model: anti-neuronal apoptosis, neuroprotection via activation of MEF2D, and inhibition of monoamine oxidase-B

B Guo, C Zheng, W Cai, J Cheng, H Wang… - Journal of agricultural …, 2016 - ACS Publications
Chrysin, a flavonoid compound existing in several plants, is applied as a dietary supplement
because of its beneficial effects on general human health and alleviation of neurological …